NCT07458503

Brief Summary

The objective of this clinical trial is to evaluate the effects of transcranial direct current stimulation (tDCS) combined with constraint-induced therapy (CIT) on upper limb motor recovery in individuals after stroke. The main questions it aims to answer are: Does the combination of tDCS and CIT improve upper limb motor function compared to CIT alone? Does the combined intervention promote changes in muscle morphology and electromyographic activity? Researchers will compare the group receiving tDCS combined with constraint-induced therapy to the group receiving constraint-induced therapy alone to determine whether the addition of cortical neuromodulation enhances motor recovery outcomes. This is a randomized, controlled, and blinded clinical trial in which participants will be divided into two groups: one group will receive tDCS combined with CIMT, and the other will undergo only CIMT. The protocol will include 18 sessions over six weeks, three times a week. Clinical and instrumental assessments will be performed before, during, and after the intervention, including the Fugl-Meyer scale for the upper limb, musculoskeletal ultrasound for morphological analysis, and surface electromyography for muscle activity assessment.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
10mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Apr 2026Apr 2027

First Submitted

Initial submission to the registry

March 3, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 9, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

April 15, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2027

Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

March 3, 2026

Last Update Submit

March 3, 2026

Conditions

Keywords

StrokeTranscranial Direct Current StimulationUpper Limb

Outcome Measures

Primary Outcomes (1)

  • Change in upper limb motor function

    Change in motor function measured by the Fugl-Meyer Assessment - Upper Extremity (FMA-UE) score

    Baseline and 15 days after completion of the 18-session intervention protocol.

Study Arms (2)

Transcranial direct current stimulation + Constraint-induced movement therapy

EXPERIMENTAL
Device: transcranial direct current stimulation (tDCS)Behavioral: Constraint-induced movement therapy

Constraint-induced movement therapy

ACTIVE COMPARATOR
Behavioral: Constraint-induced movement therapy

Interventions

For tDCS application, the Microestim tDCS model stimulator (NKL Electronic Products Ltd., Brazil) will be used, with a pair of 5 cm x 7 cm (35 cm2) sponge electrodes, which will be soaked in saline solution providing a current density of 0.04 mA/cm2 that will be within safety limits (Russo et al 2017). Regarding electrode placement, the anodic electrode will be fixed over the primary motor cortex (M1) of the affected hemisphere, corresponding to point C3 or C4, according to the international 10-20 electroencephalography system. The cathodic electrode will be positioned over the primary motor cortex of the unaffected hemisphere, at point C4 or C3, respectively, according to the same system. This choice was based on a study by Sun Ho et al (2021) that studied the effects of tDCS and ICT to improve upper limb function after stroke. Volunteers in the a-ETCC group will undergo anodal stimulation at M1 with constant direct current at an intensity of 2 mA, for 20 minutes per session.

Transcranial direct current stimulation + Constraint-induced movement therapy

At the time of applying CIMT, a sling will be used positioned on the healthy upper limb (UL), then the affected or paretic UL will be stimulated to perform tasks involving activities of daily living and/or everyday life, with the volunteers seated, in an ergonomic way and with the material used for the activities positioned on a table. The healthy UL will be restrained by the sling, while the paretic UL will perform the activities. The CIMT protocol will involve three main components: repetitive task-oriented training of the affected upper limb; the transfer package, developed to facilitate the generalization of therapeutic gains obtained in the clinical setting to the participant's daily activities; and the restriction of the unaffected upper limb, with the aim of inducing functional use of the affected limb, as described in the classic study by Taub et al. (2006). It is worth noting that the restraint of the unaffected limb will occur exclusively during the intervention period

Also known as: Constraint-Induced Movement Therapy (CIMT), Induced movement therapy
Constraint-induced movement therapyTranscranial direct current stimulation + Constraint-induced movement therapy

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (1) present a clinical diagnosis of stroke confirmed by imaging examination and/or report issued by a neurologist; (2) are in the chronic phase of the lesion with an occurrence time greater than six months; (3) hemiparesis with brachial predominance, mild to moderate motor deficit in the affected upper limb defined by a score between 19 and 55 points on the FMA-UE; (4) have minimum joint integrity to perform the movements required in the protocol with an active range of motion of at least 20° of wrist extension, 10° of extension of the metacarpophalangeal and interphalangeal joints and 20° of elbow extension considering the standard position of 90° elbow flexion, measured with a Carci® goniometer; (5) demonstrate the ability to understand and follow simple commands on the Mini Mental State Examination (MMSE) (ANNEX II) with a score higher than 23 points for literate persons and lower than 15 points for illiterate persons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

State University of Pará - Center for Biological and Health Sciences (UEPA)

Belém, Pará, 66087-662, Brazil

Location

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Direct Current StimulationConstraint Induced Movement Therapy

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological TechniquesExercise TherapyPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc Student - Principal Investigator

Study Record Dates

First Submitted

March 3, 2026

First Posted

March 9, 2026

Study Start

April 15, 2026

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

April 10, 2027

Last Updated

March 9, 2026

Record last verified: 2026-03

Locations